Micron Technology (NASDAQ:MU) announced a strategic agreement with Anthropic that includes a memory and storage supply deal, technical collaboration on AI infrastructure, and a strategic investment in Anthropic’s Series H funding round.
Revolution Medicines (NASDAQ:RVMD) began dosing patients in its global Phase 3 RASolute 305 trial for metastatic pancreatic cancer.
President Donald Trump announced that Iran has agreed to reinstate nuclear inspections by the International Atomic Energy Agency (IAEA), a development that sent ripples through global markets.
Allergan Aesthetics (NYSE:ABBV) received Health Canada approval for Boey (trenibotulinumtoxinE) to temporarily improve the appearance of moderate to severe glabellar (frown) lines in adults.
Fortitude Mining Holdings and HeartSciences (NASDAQ:HSCS) have entered into a definitive merger agreement to combine in an all-stock transaction expected to close in the second half of 2026.
Gilead Sciences (NASDAQ:GILD) announced that the European Commission has granted marketing authorization for Trodelvy (sacituzumab govitecan-hziy) as monotherapy for adult patients with unresectable or metastatic triple-negative breast cancer who have not received prior systemic therapy and are not candidates for PD-1 or PD-L1 inhibitor treatment.
Sunstone Hotel Investors (NYSE:SHO) agreed to sell the Hyatt Regency San Francisco to Blackstone Real Estate for $279 million.
Bristow Group (NYSE:VTOL) executed an agreement to acquire Berry Aviation from Acorn Capital Management for $105 million.
Veeva Systems (NYSE:VEEV) acquired Copli, a pioneer in agentic medical, legal, and regulatory solutions, and launched Veeva Falcon MLR.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas
-640x360.webp&w=3840&q=75)
